Futura Medical (LSE:FUM) Change In Receivables : £-0.98 Mil (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Change In Receivables?

Futura Medical's change in receivables for the quarter that ended in Dec. 2023 was £-0.17 Mil. It means Futura Medical's Accounts Receivable increased by £0.17 Mil from Jun. 2023 to Dec. 2023 .

Futura Medical's change in receivables for the fiscal year that ended in Dec. 2023 was £-0.97 Mil. It means Futura Medical's Accounts Receivable increased by £0.97 Mil from Dec. 2022 to Dec. 2023 .

Futura Medical's Accounts Receivable for the quarter that ended in Dec. 2023 was £1.15 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Futura Medical's Days Sales Outstanding for the six months ended in Dec. 2023 was 149.86.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Futura Medical's liquidation value for the six months ended in Dec. 2023 was £2.24 Mil.

Futura Medical Change In Receivables Historical Data

The historical data trend for Futura Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Change In Receivables Chart

Futura Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.21

0.06

-0.04

-0.19

-0.97

Futura Medical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-0.02	-0.17	-0.81	-0.17

Futura Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.98 Mil.

Futura Medical (LSE:FUM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Futura Medical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.148	/	1.398	*	91
=	149.86

2. In Ben Graham's calculation of liquidation value, Futura Medical's accounts receivable are only considered to be worth 75% of book value:

Futura Medical's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	7.714	-	6.34	+	0.75 * 1.148	+	0.5 * 0
=	2.24

Futura Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Futura Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Futura Medical (LSE:FUM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

FAMDF:USA GYX:Germany

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines